Clinical Trial

Levagen+ Efficacy Study on Diabetic Peripheral Neuropathy

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 23, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to assess the efficacy of Levagen+ supplementation for the symptoms of diabetic peripheral neuropathy (DPN) in patients with DPN. Participants will have remote visits and attend a local pathology centre for blood draws. They will take the study product for 12 weeks, from baseline to week 12 they will have remote visits every 3 weeks.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-17.
Status change: Not Yet Recruiting → Recruiting 2025-07-21
Trial Details
NCT Number NCT07028528
Lead Sponsor RDC Clinical Pty Ltd
Collaborators: Gencor Pacific Limited, Hong Kong
Conditions Diabetic Peripheral Neuropathy
Enrollment 80 participants
Start Date 2025-07-01
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2025-07-23